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Heart failure (HF) is a complex syndrome representing the clinical endpoint of many
cardiovascular diseases of different etiology. Given its prevalence, incidence and social
impact, a better understanding of HF pathophysiology is paramount to implement more
effective anti-HF therapies. Based on left ventricle (LV) performance, HF is currently
classified as follows: (1) with reduced ejection fraction (HFrEF); (2) with mid-range EF
(HFmrEF); and (3) with preserved EF (HFpEF). A central tenet of HFrEF pathophysiology
is adrenergic hyperactivity, featuring increased sympathetic nerve discharge and a
progressive loss of rhythmical sympathetic oscillations. The role of reflex mechanisms
in sustaining adrenergic abnormalities during HFrEF is increasingly well appreciated and
delineated. However, the same cannot be said for patients affected by HFpEF or HFmrEF,
whom also present with autonomic dysfunction. Neural mechanisms of cardiovascular
regulation act as “controller units,” detecting and adjusting for changes in arterial blood
pressure, blood volume, and arterial concentrations of oxygen, carbon dioxide and pH,
as well as for humoral factors eventually released after myocardial (or other tissue)
ischemia. They do so on a beat-to-beat basis. The central dynamic integration of all
these afferent signals ensures homeostasis, at rest and during states of physiological or
pathophysiological stress. Thus, the net result of information gathered by each controller
unit is transmitted by the autonomic branch using two different codes: intensity and
rhythm of sympathetic discharges. The main scope of the present article is to (i) review
the key neural mechanisms involved in cardiovascular regulation; (ii) discuss how their
dysfunction accounts for the hyperadrenergic state present in certain forms of HF;
and (iii) summarize how sympathetic efferent traffic reveal central integration among
autonomic mechanisms under physiological and pathological conditions, with a special
emphasis on pathophysiological characteristics of HF.
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“Most of our faculties lie dormant because they can rely upon Habit,
which knows what there is to be done and has no need of their
services.”
Marcel Proust
INTRODUCTION
Almost all cardiovascular disease conditions eventually
culminate in heart failure (HF), a complex and multifactorial
syndrome that remains the main cause of morbidity and
mortality worldwide (Ponikowski et al., 2016). HF stems
from progressive structural and functional deterioration of
the myocardium, due to chronic hemodynamic stress, whose
initial trigger could be of ischemic or non-ischemic origin
(Brede et al., 2002; Triposkiadis et al., 2009). Regardless of
its etiology, neurohumoral activation represents a major
contributor of HF pathophysiology. The neurohumoral
activation arises as a compensatory response in order to adjust
cardiac performance in the face of increased workload. However,
persistent hemodynamic stress results in chronic release of
neurohormones, particularly from sympathetic efferents and
the adrenal medulla (Lymperopoulos et al., 2013), which play a
major role in the progressive deterioration of cardiac function
during HF (Brede et al., 2002). A hyperadrenergic state can be
found in clinical conditions such as hypertension (Miyajima
et al., 1991), coronary artery disease and myocardial infarction
(Graham et al., 2002). As mentioned above, presence of a chronic
hyperadrenergic state paves the way for HF (Notarius et al.,
2007), yet also serves as a major index in the prognosis of HF
(Barretto et al., 2009) and as a central therapeutic target.
Depending on the status of left ventricular (LV) performance,
HF is currently classified in three clinically distinct syndromes
(Ponikowski et al., 2016). Patients exhibiting signs and/or
symptoms of HF that display LV ejection fraction (LVEF)
<40% are categorized as HF patients with reduced ejection
fraction (HFrEF) (Ponikowski et al., 2016). HF patients with
preserved systolic function (LVEF >50%), but with diastolic
dysfunction (LV end-diastolic volume index <97 ml/m2) are
now defined as HF patients with preserved ejection fraction
(HFpEF) (Ponikowski et al., 2016; van Heerebeek and Paulus,
2016). Finally, based on more recent international guidelines on
HF, a third group of HF subjects has now been identified. Those
patients who display symptoms of HF with moderately reduced
systolic function (LVEF between 40 and 50%) are now classified
as HF with mid-range EF (HFmrEF) (Ponikowski et al., 2016).
Clinically, dyspnea and exercise intolerance are fundamental
symptoms of HF. They arise at the onset of disease, and progress
according to the severity of cardiac dysfunction (Ponikowski
et al., 2016). Complex neuro-hormonal alterations are at the
foundation of these symptoms, and act in concert with increased
pulmonary venous pressure, decreased peripheral blood flow,
endothelial dysfunction and skeletal muscle abnormalities
(Floras and Ponikowski, 2015). It is well established that
perturbed reflex mechanisms sustain sympathetic hyperactivity
during HFrEF. However, substantial efforts are needed to identify
changes in neural-cardiovascular regulatory pathways in HFpEF
patients. Indeed, these patients also have prominent autonomic
dysfunction (Verloop et al., 2015). However, little is known
about the role of neural mechanisms that govern the amplitude
or frequency of bursts of autonomic activity, or the pattern of
active fiber discharge. Likewise, the central pathways that affect
sympathetic burst generation inHFmrEF andHFpEF patients are
not fully understood.
In this article, we will review and discuss old and new
acquisitions on (i) the principal neural/reflex mechanisms
accounting for cardiovascular homeostasis, (ii) how
perturbations in these “controller units” account for the
hyperadrenergic state characterizing HF; and (iii) how these
mechanisms interact under physiological conditions as well as in
subjects affected by HF of different categories.
HYPERADRENERGIC STATE IN HEART
FAILURE
Under physiological conditions, several regulatory mechanisms
work in concert in order to modulate the activity of the
autonomic nervous system. By regulating heart rate, blood
pressure and peripheral blood flow, the autonomic nervous
system dynamically adjusts the functions of the cardiovascular
system to ensure adequate levels of cardiac output will meet
the perfusion and metabolic requirements of peripheral organ
systems (Salman, 2016).
The past few decades have seen a growing research interest in
the studying of neural mechanisms of cardiovascular regulation.
This investigative attention was, and still is, justified by the
recognition that these autonomic reflex controls are critical in the
detection and correction of spontaneous changes in arterial blood
pressure, thoracic blood volumes and pressures, humoral factors
produced during myocardial ischemia and changes in arterial
concentration of oxygen, carbon dioxide and pH. These reflexes
are indeed essential to maintain whole-body homeostasis at rest
(Salman, 2016), or during ordinary physiological events, such as,
(i) changes in posture (i.e., clinostatic vs. orthostatic; Montano
et al., 1994), (ii) alterations in the sleep-wake cycle (Narkiewicz
et al., 1998; Tobaldini et al., 2017), (iii) in response to exercise
(Negrão et al., 2001), or (iv) during emotional stress (Durocher
et al., 2011).
However, during disease states affecting the cardiovascular
system, the disturbance in regulatory mechanisms may cause
autonomic dysfunction, in one or more of these neural/reflex
mechanisms, ultimately resulting in an overall sympathetic
hyperactivation and/or vagal impairment. When chronically
sustained, the resulting autonomic imbalance triggers a complex
“vicious cycle” that contributes to the onset of cardiovascular
disease (Floras and Ponikowski, 2015).
As mentioned above, a hallmark of HF is the hyperadrenergic
state, characterized by an exacerbated sympathetic nerve
discharge and a progressive loss of rhythmical sympathetic
oscillation (van de Borne et al., 1997; Barretto et al., 2009)
(Figure 1). In particular, patients with HFrEF, display eccentric
LV remodeling and systolic dysfunction, yet cardiac output
and tissue perfusion pressures are maintained. The latter two
are maintained, at least initially, by the sustained activation
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FIGURE 1 | Representative tracings of muscle sympathetic nerve activity (MSNA), blood pressure (BP) and respiration rate (RR) in a healthy subject, a
patient with heart failure with preserved ejection fraction (HFpEF) and a patient with heart failure with reduced ejection fraction (HFrEF), at rest. Note
the difference in the discharge patterns of the sympathetic outflow between healthy control subjects vs. HFpEF vs. HFrEF patients. Representative tracings of MSNA,
BP and RR are unpublished material.
of the sympathetic nervous system (SNS) and the renin-
angiotensin aldosterone system (Roig et al., 2000; Notarius
et al., 2007). Conversely, HFpEF patients exhibit LV concentric
hypertrophy, interstitial fibrosis and capillary rarefaction, with
themain functional defect contributing to diastolic dysfunction is
impaired cardiomyocyte relaxation (Paulus and Tschope, 2013).
Sympathetic overdrive has been documented in these patients as
well. Verloop and colleagues recently concluded that the current
availability of knowledge does not permit a distinguishment
on whether enhanced sympathetic activity results in HFpEF, or
HFpEF results in enhanced sympathetic activity (Verloop et al.,
2015). Moreover, whether patients with HFmrEF present with
a hyperadrenergic state, and the eventual magnitude of this
alteration, remains to be documented clinically.
Arterial Baroreflex Control
Arterial baroreflex (ABR) control is an integrated negative-
feedback system whose main role is to stabilize arterial blood
pressure in response to changes of circulatory homeostasis,
in the short-term (Salman, 2016). Stretch-sensitive receptors
located in specialized regions of the aortic arch and carotid
sinus are innervated by branches of the IX and X cranial
nerves. They discharge in response to an increase in arterial
pressure. The central projections of baroreceptor afferents
terminate primarily in the intermediate portion of the nucleus
tractus solitarii (NTS) that form asymmetric (excitatory)
synaptic contacts through glutamatergic receptors with caudal
ventrolateral medulla (CVLM) (Figure 2A). In turn, CVLM
efferent terminals form symmetric (inhibitory) synaptic contacts
through GABAergic receptors with reticulospinal and adrenergic
neurons of the rostral ventrolateral medulla (RVLM), thus
inhibiting sympathetic outflow (Pilowsky and Goodchild, 2002)
(Figure 2A). In parallel, other second-order NTS neurons
form asymmetric synaptic contacts with the dorsal motor
nucleus of the vagus nerve, maintaining an excitatory influence
upon preganglionic parasympathetic neurons (Pilowsky and
Goodchild, 2002) (Figure 2A).
Thus, an elevation in arterial blood pressure triggers an
increase in the baroreceptor firing rate to medullary nuclei
of central integration, leading to an increased discharge of
vagal efferent fibers and a decreased sympathetic outflow. The
physiological response of these combined effects results in
bradycardia and a decrease in cardiac contractility, peripheral
vascular resistance, and venous return, all acting to counter the
rise in arterial blood pressure (Kirchheim, 1976; Tank et al.,
2005). Conversely, a decrease in arterial blood pressure results in
a reduced baroreceptor firing rate. Culminating in sympathetic
excitation and parasympathetic withdrawal, thus leading to
tachycardia, increased cardiac inotropy, vascular resistance, and
venous return (Kirchheim, 1976; Tank et al., 2005).
During each beat, the ABR control is the main modulator of
the activity of the autonomic nervous system during short-term
variation of arterial pressure (Pagani and Malliani, 2000; Tank
et al., 2005). Classical studies in humans and animals have clearly
proved that the hyperadrenergic state of HFrEF is accompanied
by blunting of ABR (Ferguson et al., 1992; Grassi et al., 2001)
(Table 1).
As we learned before, in HFrEF patients that display eccentric
remodeling and systolic dysfunction, cardiac output and tissue
perfusion pressure are maintained via sustained neurohormonal
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FIGURE 2 | Classical schematic diagram of arterial baroreflex control (A), cardiopulmonary reflex (B), cardiac sympathetic afferent reflex (C), and arterial
chemoreflex (D). NTS, nucleus tractus solitarii; NA, nucleus ambiguus; DMV, dorsal motor nucleus of the vagus; CVLM, caudal ventrolateral medulla; RVLM, rostral
ventrolateral medulla; PVN, paraventricular nucleus of the hypothalamus; A5, noradrenergic neurons of the ventrolateral pons; RTN/pFRG, retrotrapezoid
nucleus/parafacial respiratory group; VRC, ventral respiratory column; BötC, Bötzinger complex; pre-BötC, pre-Bötzinger complex; Rvrg, rostral ventral respiratory
group; eSN, efferent sympathetic nerve; PN, phrenic nerve; VN, vagus nerve.
TABLE 1 | Autonomic reflex control of sympathetic nerve activity in
patients with heart failure.
HFrEF HFpEF
Arterial Baroreflex Blunted –
Cardiopulmonary Reflex Paradoxical –
Cardiac Sympathetic Afferents Reflex Exacerbateda –
Arterial Chemoreflex Exacerbated Exacerbateda
HFrEF, heart failure with reduced ejection fraction; HFmrEF, heart failure with mid-range
ejection fraction; HFpEF, heart failure with preserved ejection fraction.
aOnly in animal model.
activation (Zucker et al., 2004). In the heart, chronic sympathetic
activation promotes myocardial hypertrophy and vascular
remodeling (Zucker et al., 2004; Floras and Ponikowski, 2015).
Moreover, vascular remodeling could play an important role
in the maintenance of sympathetic drive in HF, by affecting
the afferent branch of ABR. In rats with ischemia-induced HF,
the gain of afferent aortic depressor nerve is reduced (Rondon
et al., 2006). Thus, arterial stiffness could impair the mechanical
transduction of baroreceptors, therefore affecting afferent traffic.
No studies, to our knowledge, have directly examined the
impact of ABR control on sympathetic nerve activity in patients
with HFpEF and HFmrEF (Table 1). However, data from an
experimental study suggest that baroreflex dysfunction of heart
rate is associated with cardiac diastolic dysfunction in rats,
independent of other present risk factors (Mostarda et al., 2011).
Moreover, patients with HFpEF are generally older, more often
female, and have a high prevalence of comorbidities, such as
chronic hypertension, obesity, metabolic syndrome and type 2
diabetes mellitus (Paulus and Tschope, 2013; van Heerebeek
and Paulus, 2016). All these conditions have been associated,
in part, with baroreflex dysfunction (Matsukawa et al., 1991,
1994; Trombetta et al., 2010; Holwerda et al., 2016). In particular,
an association exists between hypertension and vascular injury
(Dao et al., 2005), affecting the elastic properties of the large
vessels (Humphrey et al., 2016; Smulyan et al., 2016). This, in
turn, could impact the efficiency of ABR control in patients with
HFpEF. Therefore, myocardial remodeling and arterial stiffness
can affect ABR arc function through different pathophysiological
mechanisms, leading to sympathetic hyperactivation both in
HFrEF and HFpEF patients.
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Cardiopulmonary Reflex
The cardiopulmonary reflex arc is liable for detecting filling
pressure in low-pressure cardiac chambers. In doing so, it
contributes to the control of volemic conditions through the
interaction between negative- and positive-feedbackmechanisms
(Salman, 2016). Several receptor subtypes, located in the heart
and lungs, contribute to this reflex arc. They are mechano-
sensitive and closely linked to neuronal pathways via overlapping
brainstem networks. Whereas, most of these receptors are
innervated by unmyelinated afferents of the vagus nerve (Type
C) and are activated at higher intensities, a smaller portion is
made of myelinated fibers of the vagus nerve (Type A) and are
activated at lower intensities (Salman, 2016). Cardiopulmonary
vagal afferents are mainly involved in neurohumoral regulation
of systemic blood volume. When stimulated, they convey
information to medullary nuclei of central integration (i.e., NTS)
that form a trisynaptic intramedullary pathway similar to that
described for the ABR (Salman, 2016) (Figure 2B).
Firstly, fluctuations of lower intensities activate sensory
afferent fibers (Type A) located in the walls of the atria and
in the atrial-caval junction, determining tachycardia through
sympathetic activation. Atrial stretch results in the release
of atrial natriuretic peptide by atrial myocytes, which act to
increase renal blood flow and Na+ diuresis, reducing volume and
keeping cardiac output relatively constant during the increase of
venous return (Salman, 2016). In stark contrast, fluctuations of
higher intensities activate Type C sensory afferent fibers located
in cardiac chambers, strengthening and enhancing the action
of ABR by means of similar negative-feedback mechanisms.
However, during hypovolemia, the neurohormonal response acts
to reduce heart rate (bradycardia) and urinary volume in order to
correct the initial drop in venous return (Salman, 2016).
In 1990, Seals and colleagues observed that during controlled
tidal breathing (30% of inspiratory capacity at 12 breath/min),
approximately 65% of the sympathetic bursts occur during
the expiratory phase, suggesting an influence of breathing on
sympathetic outflow (Seals et al., 1990). In turn, increasing
the depth of breathing (e.g., 70% of inspiratory capacity at 12
breath/min) has great influence on the within-breath modulation
of muscle sympathetic nerve activity (MSNA), producing near
complete sympathoinhibition from onset-mid inspiration to
early-mid expiration (Seals et al., 1990).
The effects of cardiopulmonary reflex activation and
deactivation on sympathetic outflow has been evaluated
in humans via MSNA recording during lower body
negative/positive pressures. Previously demonstrated,
deactivation of cardiopulmonary reflex during application
of non-hypotensive lower body negative pressure (LBNP)
showed an increase in the sympathetic efferent traffic in
healthy subjects (Millar et al., 2015). Conversely, activation of
cardiopulmonary reflex during application of non-hypertensive
lower body positive pressure (LBPP) was associated with a
decrease in sympathetic activity in healthy subjects (Millar et al.,
2015).
Alterations of the autonomic neural reflex responses due to
changes in cardiopulmonary loading conditions have been well
documented in HFrEF patients (Azevedo et al., 2000; Floras and
Ponikowski, 2015). Recently, Millar and colleagues reported that
despite a preserved response of MSNA during deactivation of
the cardiopulmonary reflex arc, non-hypertensive LBPP does not
change the burst frequency of sympathetic outflow in patients
with HFrEF (Millar et al., 2015). This paradoxical sympathetic
activation in response to increasing filling pressure suggests that
cardiopulmonary reflex contributes to the complex generation of
autonomic dysregulation of HFrEF. Similar evidence in HFpEF
and HFmrEF patients is lacking (Table 1).
Cardiac Sympathetic Afferent Reflex
The cardiac sympathetic afferent reflex (CSAR) is a positive
feedback mechanism involved in the central transmission of
nociceptive information from the heart (Chen et al., 2015). The
receptors of this reflex arc are the cardiac sympathetic afferent
endings that innervate the superficial epicardial layers of the
ventricles. Although the exact neural pathways of CSAR are not
yet well understood, there is a growing consensus of opinion that
the central projections of sympathetic afferents located in the
dorsal root ganglia of the C8–T9 spinal segments (especially T2–
T6) form excitatory synapses in the hypothalamic paraventricular
nucleus (PVN), NTS and RVLM. These stations in turn centrally
process the peripheral information and, when stimulated,
induce an increase in sympathetic outflow (Chen et al., 2015)
(Figure 2C). Thus, mechanical distension of the ventricles
and/or endogenous humoral factors produced in myocardium
during myocardial ischemia, such as bradykinin, adenosine and
reactive oxygen species (ROS), can stimulate cardiac sympathetic
afferents, thereby increasing the sympathetic outflow directed
to the heart, arteries and kidneys (Chen et al., 2015). All these
mechanisms take part in the excessive sympathetic outflow that
characterizes HF (Malliani and Montano, 2002; Zhu et al., 2004;
Wang et al., 2014) (Table 1). Furthermore, once overtly dilated,
the heart tends to utilize more oxygen, owing to increased
cardiac wall tension. This need renders the heart more prone
to “relative ischemia,” a functional feature often observed in HF
patients. In turn, this condition is accompanied by the release of
endogenous substances such as bradykinin and adenosine that
stimulate the ventricular sympathetic afferents endings, resulting
in increased sympathetic outflow due to positive feedback
mechanism. Furthermore, chronic myocardial stretch due to
volume overload can cause an upregulation of the kallikrein-
kinin system, followed by an increase in bradykinin content in
the interstitial fluid that ultimately mediates mast cell infiltration
and extracellular matrix loss (Wei et al., 2012).
In a clinical context, it is well known that patients with acute
decompensated HF are very sensitive to volume overload because
they have volume intolerance, regardless of the magnitude of
residual LVEF. Moreover, during acute decompensated HF and
pulmonary congestion, both arterial pressure and heart rate
are frequently more elevated (De Luca et al., 2007). It is still
unclear how the positive feedbackmechanismmediated by CSAR
would eventually prevail over the negative one mediated by
the vagal afferents. However, there is an attractive corollary
hypothesis to consider (Malliani and Montano, 2002). For
example, afferent vagal fibers from the atria normally display
a burst of impulses per cardiac cycle. In the case of Type A
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receptors, this event occurs in coincidence with atrial systole
(Paintal, 1971). In central structures, rhythmic afferent bursts
can prompt a sequence of excitatory and inhibitory postsynaptic
potentials (Spyer, 1982). During volume loading, Type A atrial
vagal receptors also discharge during diastole (Recordati et al.,
1976), and this more continuous firing may blunt the capability
of generating inhibitory postsynaptic potentials in the central
circuitry. Similar changes in firing patterns may characterize the
majority of vagal cardiopulmonary receptors, thus explaining
their reduced efficacy in exerting an efficient reflex restraint
on the sympathetic outflow (Malliani and Montano, 2002).
Conversely, under normal conditions, sympathetic afferent fibers
do not display bursts of impulses. Rather, at most, they exhibit a
more sparse and spontaneous activity with one action potential
per cardiac cycle (Malliani, 1982). Thus, independent of its
rhythmic relationship with the cardiac cycle, an increased afferent
sympathetic barrage would retain its capability of exciting the
sympathetic outflow (Malliani and Montano, 2002).
Arterial Chemoreflex
In response to environmental challenges, the maintenance of
homeostasis depends also on the integration between neural
mechanisms that adjust arterial levels of oxygen (O2), carbon
dioxide (CO2) and potential of hydrogen (pH). To this end,
the arterial chemoreflex control comprises central chemoreceptors
in the brainstem that respond to hypercapnia and respiratory
acidosis; and peripheral chemoreceptors in the carotid bodies
(located near the internal carotid arteries) that respond primarily
to hypoxia (Guyenet, 2000; Barnett et al., 2017).
During hypercapnia and respiratory acidosis, chemosensitive
neurons located in retrotrapezoid nucleus/parafacial respiratory
group (RTN/pFRG) are stimulated, sending excitatory inputs to
the pre-sympathetic neurons of the RVLM that form excitatory
synaptic contacts with noradrenergic neurons (A5 group) in the
ventrolateral pons (Barnett et al., 2017) (Figure 2D). In parallel,
second-order neurons of RTN/pFRG send excitatory inputs to
the pre-Bötzinger complex–a cluster of neurons responsible
for generating the breathing rhythm located in the ventral
respiratory column (VRC). Here, they form excitatory synaptic
contacts with the rostral ventral respiratory group (rVRG) and
project to motor neurons that give rise to the phrenic nerve
(Barnett et al., 2017) (Figure 2D).
During hypoxia, the central projections of peripheral
chemoreceptor afferents (cranial nerve IX) terminate primarily
in the commissural portion of the NTS that, by means of second-
order neurons, then form excitatory synapses with RVLM,
RTN/pFRG and the pre-Bötzinger complex (Guyenet, 2000;
Barnett et al., 2017) (Figure 2D).
Therefore, the stimulation of chemoreflex by hypoxia and/or
hypercapnia induces a simultaneous increase of sympathetic
outflow and ventilation, thus optimizing tissue perfusion and
blood gas uptake/delivery (Guyenet, 2000; Barnett et al., 2017)
(Figure 2D).
In HFrEF, reduction in organ perfusion due to reduced
cardiac output, promotes changes in oxygen delivery, thereby
impairing peripheral chemoreflex function in HFrEF patients.
In turn, chemoreflex dysfunction contributes to sympathetic
hyperactivity, hyperventilation and the associated breathing
instability typically found in HFrEF subjects (Schultz et al., 2015).
Accordingly, Di Vanna and collaborators demonstrated that the
activity of muscle sympathetic nerves in response to central and
peripheral chemoreceptor stimulation is exacerbated in patients
with HFrEF (Di Vanna et al., 2007) (Table 1).
In addition, it has been postulated that oxidative stress (i.e.,
increased ROS emission mainly from enhanced NADPH oxidase
activity) is also central in activating chemoreceptors of the carotid
bodies (Morgan et al., 2016). Oxidative stress is known to activate
the carotid body in HF (Schultz et al., 2015). We now know
that both circulating and local tissue levels of the pro-oxidant
angiotensin II peptide are elevated in HF (Li et al., 2006).
Angiotensin II activates NADPH oxidase to enhance superoxide
production, which in turn enhances the excitability of the carotid
body glomus cells and central autonomic neurons via the AT1
receptor (Li et al., 2007). The angiotensin II-superoxide pathway
augments the sensitivity of the carotid body chemoreceptors, at
least in part, by inhibiting oxygen-sensitive potassium channels
in the carotid body glomus cells (Schultz et al., 2015).
Regardless of the low cardiac output, diverse comorbidities
such as hypertension (Touyz, 2004), diabetes (Henriksen et al.,
2011), and obstructive sleep apnea (Lavie, 2015) are associated
with increased oxidative stress that may lead to carotid body
chemoreceptor dysfunction. These comorbidities are frequent in
patients with HFpEF or HFmrEF, thus suggesting the presence
of chemoreflex dysfunction in these patients. In fact, Toledo
and colleagues recently reported that the central chemoreflex
is enhanced in HFpEF (Toledo et al., 2017). These authors
observed that the activation of the central chemoreflex pathway
by hypercapnia exacerbates sympatho-vagal imbalance in HFpEF
rats, and that sympathetic blockade with propranolol attenuates
the response of cardiac sympathetic modulation. In addition,
these authors showed that neuronal activation in the RVLM was
increased in HFpEF rats compared with sham rats (Toledo et al.,
2017). However, further studies are needed to better understand
the mechanistic intricacies of these new findings.
Further to this, to the best of our knowledge, there are
no studies testing sympathetic nerve activity in response to
chemoreceptor stimulation in patients with HFpEF or HFmrEF.
Central Integration of Autonomic Reflexes
Autonomic reflexes are considered as distinct controllers units.
However, multiple sites of interaction among these reflex arcs
have been documented (Du and Chen, 2006; Chen et al.,
2015). They are outlined in Figure 3. NTS is the first synaptic
station of the afferents in the central nervous system. It plays
a pivotal role in the modulation of the autonomic efferent
activity directed to the cardiovascular system (Machado et al.,
1997). In order to produce a proper autonomic response,
information from several relay stations must be processed at
the NTS level, where all the projections of many and complex
neural networks are then organized in different hierarchical
levels (Smith et al., 2009; Chen et al., 2015). For instance,
activation of CSAR depresses ABR and enhances the arterial
chemoreflex via central integration (Du and Chen, 2006; Chen
et al., 2015) (Figure 3A). The afferent pathways of these
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FIGURE 3 | Hypothetical representation of the reflex mechanisms considered as “controller units,” and their complex and dynamic interaction in a
physiological condition (A) and during heart failure (B). CSAR, cardiac sympathetic afferents reflex; PVN, paraventricular nucleus of the hypothalamus; SN,
sympathetic nerve; VN, vagus nerve. Note that the sustained hyperadrenergic state in patients with HF occurs due to the predominance of inputs of excitatory
mechanisms on inhibitory mechanisms.
reflex mechanisms project to the NTS, and numerous lines of
investigation attests that baroreflex dysfunction of the MSNA is
the consequence of and not the cause of the reflex sympathetic
excitation seen in HF patients (Du and Chen, 2006; Despas
et al., 2012) (Figure 3B). In this regard, an experimental
study showed that electrical stimulation of the central end
of the left cardiac sympathetic nerve blunts ABR sensitivity
by 42% (Figure 3A), and this effect is abolished after intra-
cerebroventricular injection of losartan (Gao et al., 2004).
This evidence suggests that stimulation of cardiac sympathetic
afferents reduces ABR sensitivity via central AT1 receptors (Gao
et al., 2004).
AngII is expressed in the NTS, and one of the signaling
mechanisms by which AT1 receptors influence the NTS neurons
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involves the production of ROS by NADPH oxidase. NADPH
oxidase activation in turn enhances voltage-gated L-type Ca2+
currents in the medial NTS neurons, thereby contributing to the
deleterious effects exerted by AngII in the cardiovascular system
(Wang et al., 2004, 2006). As such, we cannot rule out a priori
that AngII, via the AT1 receptor, plays a pivotal role in both
inhibitory and excitatory reflexes in the central nervous system
during HF. Accordingly, the augmented cardiac sympathetic
afferent input can contribute to the exacerbated chemoreflex
function in HF in a AT1 receptor-dependent manner in the
NTS (Wang et al., 2008). Indeed, AT1 receptors in the NTS
are upregulated, and blockade of these receptors normalized the
exaggerated response of the chemoreflex/CSAR in HF (Wang
et al., 2008).
In another study, Gan and colleagues observed that the
CSAR is enhanced not only in HF rats, but also in rats with
HF harboring bilateral vagotomy and ABR denervation (Gan
et al., 2011). However, vagotomy and baroreceptor denervation
augmented basal and AngII-stimulated CSAR response in the
PVN (Gan et al., 2011). This study revealed that the activity
of arterial baroreceptor and vagal afferents inhibit the CSAR
(Figure 3B), while enhancing the CSAR discharge in response to
AngII in the PVN of HF rats (Gan et al., 2011).
When the interaction between the chemoreflex and ABR is
concerned (Figure 3A), we know that isocapnic hyperventilation
(i.e., ventilation > 35 l/min at 15 breath/min) stimulates the
chemoreflex and blunts ABR gain (van de Borne et al., 2000).
On the other hand, the cardiovascular effect of chemoreflex
stimulation also encompasses a rise in arterial blood pressure,
which in turn, stimulates the arterial baroreceptors, while
blunting the chemoreflex response (Somers et al., 1991)
(Figure 3A).
Interestingly, Despas and colleagues have shown that elevated
chemosensitivity attenuated ABR control of sympathetic nerve
activity, and that deactivation of carotid chemoreceptors
increased the ABR gain in patients with HFrEF (Despas et al.,
2012) (Figure 3B). Together, this evidence suggests that the
chemoreflex-related rise in sympathetic activity is not only
mediated by an oxygen sensing mechanism, but also indirectly
(i.e., through the involvement of ABR in patients with HFrEF;
Despas et al., 2012). In stark contrast, the central integration
among autonomic reflexes in patients with HFpEF and HFmrEF
remains to be decodified.
QUESTIONS TO PONDER FOR FUTURE
STUDIES
The relevance of the role and the modalities by which altered
autonomic reflexes contribute to sympathetic hyperactivation
in HFrEF are becoming increasingly clear. In contrast, little
knowledge is currently available regarding this aspect in
subjects with HFpEF or HFmrEF. Therefore, the new HF
classification is likely to bring to the table additional, important
questions concerning the role of autonomic control/reflexes
in HF onset and progression. Notwithstanding, there are still
major, general questions that pertain to the role of autonomic
reflexes in HF pathophysiology, irrespective of its etiology or
clinical classification. First and foremost, it is still unknown
what is the cutoff and saturation point of the autonomic
nervous system in the effector organ. As mentioned earlier,
the information emanating from the central integration of
many reflex mechanisms is transmitted by the autonomic fibers
using intensity and rhythm of firing as codes. Importantly,
certain clinical conditions can lead to the collapse of the
autonomic nervous system and to the loss of rhythmicity of
cardiovascular variability (Montano et al., 2009). Due to random
distribution of spikes during time, the sympathetic afferent can be
expressed in terms of phasic and tonic activities, thus reflecting
the dynamic integration of the reflex mechanisms controlling
cardiovascular functions. The tonic and phasic activities of
cardiovascular variabilities are coupled and synchronized in
healthy individuals. However, HFrEF patients with NYHA
functional classes III and/or IV can have a paradoxical pattern
of sympathetic outflow, with a marked increase in tonus in
the absence of low frequency oscillations, not only in heart
rate variability, but also in sympathetic nerve variability (van
de Borne et al., 1997). Thus, the interpretation of oscillatory
patterns of sympathetic activity, together with the analysis of
heart rate and arterial pressure variability’s, could shed new
light on the saturation of the autonomic nervous system;
not only in HFrEF patients, but also in those suffering from
HFpEF or HFmrEF patients. Another aspect that warrants
further investigation is the interpretation of both codes. More
specifically, an additional approach should be envisioned to
obtain a distinctive profile of autonomic nervous control on the
effector organ (autonomic modulation), or put differently, on
the ability of autonomic nervous system to induce variations
(i.e., heart rate and/or arterial pressure). The clinical significance
of this ability is not yet completely understood, but it appears
to have clinically relevant implications. In contrast to HFrEF,
no clinical trials have documented an effective treatment for
patients with HFmrEF and/or HFpEF. Therefore, due to the
new classifications of HF, revisiting the autonomic reflexes
and hyperadrenergic state in these new categories of HF
patients could certainly offer new angles into the exploration of
autonomic nervous system and therapeutic perspectives for these
patients.
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